Skip to main content
Top
Published in: Basic Research in Cardiology 6/2011

Open Access 01-11-2011 | Original Contribution

K201 (JTV-519) alters the spatiotemporal properties of diastolic Ca2+ release and the associated diastolic contraction during β-adrenergic stimulation in rat ventricular cardiomyocytes

Authors: E. B. Elliott, H. Hasumi, N. Otani, T. Matsuda, R. Matsuda, N. Kaneko, G. L. Smith, Christopher M. Loughrey

Published in: Basic Research in Cardiology | Issue 6/2011

Login to get access

Abstract

K201 has previously been shown to reduce diastolic contractions in vivo during β-adrenergic stimulation and elevated extracellular calcium concentration ([Ca2+]o). The present study characterised the effect of K201 on electrically stimulated and spontaneous diastolic sarcoplasmic reticulum (SR)-mediated Ca2+ release and contractile events in isolated rat cardiomyocytes during β-adrenergic stimulation and elevated [Ca2+]o. Parallel experiments using confocal microscopy examined spontaneous diastolic Ca2+ release events at an enhanced spatiotemporal resolution. 1.0 μmol/L K201 in the presence of 150 nmol/L isoproterenol (ISO) and 4.75 mmol/L [Ca2+]o significantly decreased the amplitude of diastolic contractions to ~16% of control levels. The stimulated free Ca2+ transient amplitude was significantly reduced, but stimulated cell shortening was not significantly altered. When intracellular buffering was taken into account, K201 led to an increase in action potential-induced SR Ca2+ release. Myofilament sensitivity to Ca2+ was not changed by K201. Confocal microscopy revealed diastolic events composed of multiple Ca2+ waves (2–3) originating at various points along the cardiomyocyte length during each diastolic period. 1.0 μmol/L K201 significantly reduced the (a) frequency of diastolic events and (b) initiation points/diastolic interval in the remaining diastolic events to 61% and 71% of control levels respectively. 1.0 μmol/L K201 can reduce the probability of spontaneous diastolic Ca2+ release and their associated contractions which may limit the propensity for the contractile dysfunction observed in vivo.
Appendix
Available only for authorised users
Literature
1.
go back to reference Andersson KB, Birkeland JAK, Finsen AV, Louch WE, Sjaastad I, Wang Y, Chen J, Molkentin JD, Chien KR, Sejersted OM, Christensen G (2009) Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol 47:180–187. doi:10.1016/j.yjmcc.2009.03.013 PubMedCrossRef Andersson KB, Birkeland JAK, Finsen AV, Louch WE, Sjaastad I, Wang Y, Chen J, Molkentin JD, Chien KR, Sejersted OM, Christensen G (2009) Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol 47:180–187. doi:10.​1016/​j.​yjmcc.​2009.​03.​013 PubMedCrossRef
2.
go back to reference Colotti G, Zamparelli C, Verzili D, Mella M, Loughrey CM, Smith GL, Chiancone E (2006) The W105G and W99G sorcin mutants demonstrate the role of the D helix in the Ca(2+)-dependent interaction with annexin VII and the cardiac ryanodine receptor. Biochemistry 45:12519–12529. doi:10.1021/bi060416a PubMedCrossRef Colotti G, Zamparelli C, Verzili D, Mella M, Loughrey CM, Smith GL, Chiancone E (2006) The W105G and W99G sorcin mutants demonstrate the role of the D helix in the Ca(2+)-dependent interaction with annexin VII and the cardiac ryanodine receptor. Biochemistry 45:12519–12529. doi:10.​1021/​bi060416a PubMedCrossRef
3.
go back to reference Currie S, Elliott EB, Smith GL, Loughrey CM (2011) Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective. Pharmacol Ther 131(2):204–220. doi:10.1016/j.pharmthera.2011.02.006 PubMedCrossRef Currie S, Elliott EB, Smith GL, Loughrey CM (2011) Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective. Pharmacol Ther 131(2):204–220. doi:10.​1016/​j.​pharmthera.​2011.​02.​006 PubMedCrossRef
4.
go back to reference Eisner DA, Choi HS, Diaz ME, O’Neill SC, Trafford AW (2000) Intergrative analysis of calcium cycling in cardiac muscle. Circ Res 87:1087–1094PubMed Eisner DA, Choi HS, Diaz ME, O’Neill SC, Trafford AW (2000) Intergrative analysis of calcium cycling in cardiac muscle. Circ Res 87:1087–1094PubMed
7.
go back to reference Hilliard FA, Steele DS, Laver D, Yang Z, Le Marchand SJ, Chopra N, Piston DW, Huke S, Knollmann BC (2010) Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol 48:293–301. doi:10.1016/j.yjmcc.2009.10.005 PubMedCrossRef Hilliard FA, Steele DS, Laver D, Yang Z, Le Marchand SJ, Chopra N, Piston DW, Huke S, Knollmann BC (2010) Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol 48:293–301. doi:10.​1016/​j.​yjmcc.​2009.​10.​005 PubMedCrossRef
8.
go back to reference Hove-Madsen L, Bers DM (1993) Passive Ca buffering and SR Ca uptake in permeabilized rabbit ventricular myocytes. Am J Physiol 264:C677–C686PubMed Hove-Madsen L, Bers DM (1993) Passive Ca buffering and SR Ca uptake in permeabilized rabbit ventricular myocytes. Am J Physiol 264:C677–C686PubMed
10.
go back to reference Inagaki K, Kihara Y, Hayashida W, Izumi T, Iwanaga Y, Yoneda T, Takeuchi Y, Suyama K, Muso E, Sasayama S (2000) Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium. Circulation 101:797–804PubMed Inagaki K, Kihara Y, Hayashida W, Izumi T, Iwanaga Y, Yoneda T, Takeuchi Y, Suyama K, Muso E, Sasayama S (2000) Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium. Circulation 101:797–804PubMed
11.
go back to reference Inagaki K, Kihara Y, Izumi T, Sasayama S (2000) The cardioprotective effects of a new 1, 4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts. Cardiovasc Drugs Ther 14:489–495. doi:10.1023/A:1007884905461 PubMedCrossRef Inagaki K, Kihara Y, Izumi T, Sasayama S (2000) The cardioprotective effects of a new 1, 4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts. Cardiovasc Drugs Ther 14:489–495. doi:10.​1023/​A:​1007884905461 PubMedCrossRef
12.
go back to reference Kaneko N (1994) New 1, 4-benzothiazepine derivative, K201, demonstrates cardio-protective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug Dev Res 33:429–438CrossRef Kaneko N (1994) New 1, 4-benzothiazepine derivative, K201, demonstrates cardio-protective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug Dev Res 33:429–438CrossRef
13.
go back to reference Kaneko N, Matsuda R, Nakajima T, Shinozaki T, Ohtani N, Oda K, Hasumi H, Shimamoto K (2006) Norepinephrine-induced diastolic dysfunction with aortic valve opening under calcium-loading in rats. Drug Dev Res 67:511–518CrossRef Kaneko N, Matsuda R, Nakajima T, Shinozaki T, Ohtani N, Oda K, Hasumi H, Shimamoto K (2006) Norepinephrine-induced diastolic dysfunction with aortic valve opening under calcium-loading in rats. Drug Dev Res 67:511–518CrossRef
14.
go back to reference Kaneko N, Matsuda R, Ohtani N, Nakajima T, Arikawa T, Suzuki H, Toyoda S, Kikuchi M, Hata Y, Abe S, Taguchi I, Shimamoto K (2006) K201 improves norepinephrine-induced diastolic dysfunction with preserved ejection fraction. Drug Dev Res 67:852–861CrossRef Kaneko N, Matsuda R, Ohtani N, Nakajima T, Arikawa T, Suzuki H, Toyoda S, Kikuchi M, Hata Y, Abe S, Taguchi I, Shimamoto K (2006) K201 improves norepinephrine-induced diastolic dysfunction with preserved ejection fraction. Drug Dev Res 67:852–861CrossRef
16.
go back to reference Kimura J, Kawahara M, Sakai E, Yatabe J, Nakanishi H (1999) Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes. Jpn J Pharmacol 79:275–281PubMedCrossRef Kimura J, Kawahara M, Sakai E, Yatabe J, Nakanishi H (1999) Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes. Jpn J Pharmacol 79:275–281PubMedCrossRef
17.
go back to reference Kiriyama K, Kiyosue T, Wang JC, Dohi K, Arita M (2000) Effects of JTV-519, a novel anti-ischaemic drug, on the delayed rectifier K+ current in guinea-pig ventricular myocytes. Naunyn-Schmiedeberg’s Arch Pharmacol 361:646–653. doi:10.1007/s002100000230 CrossRef Kiriyama K, Kiyosue T, Wang JC, Dohi K, Arita M (2000) Effects of JTV-519, a novel anti-ischaemic drug, on the delayed rectifier K+ current in guinea-pig ventricular myocytes. Naunyn-Schmiedeberg’s Arch Pharmacol 361:646–653. doi:10.​1007/​s002100000230 CrossRef
19.
go back to reference Schlotthauer K, Bers DM (2000) Sarcoplasmic Reticulum Ca2+ release causes myocyte depolarisation. Circ Res 87:774PubMed Schlotthauer K, Bers DM (2000) Sarcoplasmic Reticulum Ca2+ release causes myocyte depolarisation. Circ Res 87:774PubMed
20.
go back to reference Schmidt AG, Zhai J, Carr AN, Gerst MJ, Lorenz JN, Pollesello P, Annila A, Hoit BD, Kranias EG (2002) Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure. Cardiovasc Res 56:248–259. doi:10.1016/S0008-6363(02)00541-2 PubMedCrossRef Schmidt AG, Zhai J, Carr AN, Gerst MJ, Lorenz JN, Pollesello P, Annila A, Hoit BD, Kranias EG (2002) Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure. Cardiovasc Res 56:248–259. doi:10.​1016/​S0008-6363(02)00541-2 PubMedCrossRef
21.
go back to reference Seidler T, Loughrey CM, Zibrova D, Kettlewell S, Teucher N, Kogler H, Hasenfuss G, Smith GL (2007) Overexpression of FK-506 binding protein 12.0 modulates excitation contraction coupling in adult rabbit ventricular cardiomyocytes. Circ Res 101:1020–1029. doi:10.1161/CIRCRESAHA.107.154609 PubMedCrossRef Seidler T, Loughrey CM, Zibrova D, Kettlewell S, Teucher N, Kogler H, Hasenfuss G, Smith GL (2007) Overexpression of FK-506 binding protein 12.0 modulates excitation contraction coupling in adult rabbit ventricular cardiomyocytes. Circ Res 101:1020–1029. doi:10.​1161/​CIRCRESAHA.​107.​154609 PubMedCrossRef
22.
go back to reference Sossalla S, Maurer U, Schotola H, Hartmann N, Didie M, Zimmermann WH, Jacobshagen C, Wagner S, Maier LS (2011) Diastolic dysfunction and arrhythmias caused by overexpression of CaMIIδ can be reversed by inhibition of late Na+ current. Basic Res Cardiol 106:263–272. doi:10.1007/s00395-010-0136 PubMedCrossRef Sossalla S, Maurer U, Schotola H, Hartmann N, Didie M, Zimmermann WH, Jacobshagen C, Wagner S, Maier LS (2011) Diastolic dysfunction and arrhythmias caused by overexpression of CaMIIδ can be reversed by inhibition of late Na+ current. Basic Res Cardiol 106:263–272. doi:10.​1007/​s00395-010-0136 PubMedCrossRef
23.
24.
go back to reference Toischer K, Lehnart SE, Tenderich G, Milting H, Korfer R, Schmitto JD, Schondube FA, Kaneko N, Loughrey CM, Smith GL, Hasenfuss G, Seidler T (2010) K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum. Basic Res Cardiol 105:279–287. doi:10.1007/s00395-009-0057-8 PubMedCrossRef Toischer K, Lehnart SE, Tenderich G, Milting H, Korfer R, Schmitto JD, Schondube FA, Kaneko N, Loughrey CM, Smith GL, Hasenfuss G, Seidler T (2010) K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum. Basic Res Cardiol 105:279–287. doi:10.​1007/​s00395-009-0057-8 PubMedCrossRef
26.
go back to reference Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR (2004) Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304:292–296. doi:10.1126/science.1094301 PubMedCrossRef Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR (2004) Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304:292–296. doi:10.​1126/​science.​1094301 PubMedCrossRef
27.
go back to reference Wehrens XHT, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, Cheng Z, Deng SX, de Windt LJ, Landry DW, Marks AR (2005) Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. PNAS 102:9607–9612. doi:10.1073/pnas.0500353102 PubMedCrossRef Wehrens XHT, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, Cheng Z, Deng SX, de Windt LJ, Landry DW, Marks AR (2005) Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. PNAS 102:9607–9612. doi:10.​1073/​pnas.​0500353102 PubMedCrossRef
29.
go back to reference Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Ohkusa T, Kohno M, Matsuzaki M (2003) FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107:477–484. doi:10.1161/01.CIR.0000044917.74408.BE PubMedCrossRef Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Ohkusa T, Kohno M, Matsuzaki M (2003) FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107:477–484. doi:10.​1161/​01.​CIR.​0000044917.​74408.​BE PubMedCrossRef
Metadata
Title
K201 (JTV-519) alters the spatiotemporal properties of diastolic Ca2+ release and the associated diastolic contraction during β-adrenergic stimulation in rat ventricular cardiomyocytes
Authors
E. B. Elliott
H. Hasumi
N. Otani
T. Matsuda
R. Matsuda
N. Kaneko
G. L. Smith
Christopher M. Loughrey
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Basic Research in Cardiology / Issue 6/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-011-0218-4

Other articles of this Issue 6/2011

Basic Research in Cardiology 6/2011 Go to the issue